Home/Filings/4/0001127602-12-017205
4//SEC Filing

Bogusz Patricia 4

Accession 0001127602-12-017205

CIK 0001014739other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 2:59 PM ET

Size

20.3 KB

Accession

0001127602-12-017205

Insider Transaction Report

Form 4
Period: 2012-05-14
Bogusz Patricia
Vice President, Finance
Transactions
  • Exercise/Conversion

    Common Stock, Par Value $0.0001 Per Share

    2012-05-14$6.49/sh+5,000$32,4508,028 total
  • Exercise/Conversion

    Common Stock, Par Value $0.0001 Per Share

    2012-05-14$2.47/sh+9,000$22,23017,028 total
  • Sale

    Common Stock, Par Value $0.0001 Per Share

    2012-05-14$7.52/sh14,000$105,2803,028 total
  • Exercise/Conversion

    Employee Stock Option

    2012-05-145,0000 total
    Exercise: $6.49From: 2006-10-24Exp: 2015-10-24Common Stock, $.0001 Par Value (5,000 underlying)
  • Exercise/Conversion

    Employee Stock Option

    2012-05-149,0000 total
    Exercise: $2.47From: 2007-11-01Exp: 2016-11-01Common Stock, $.0001 Par Value (9,000 underlying)
Holdings
  • Common Stock, $.0001 Par Value

    7,875
  • Employee Stock Option

    Exercise: $6.52From: 2009-04-29Exp: 2018-04-29Common Stock, $.0001 Par Value (19,687 underlying)
    19,687
  • Employee Stock Option

    Exercise: $2.73From: 2010-04-28Exp: 2019-04-28Common Stock, $.0001 Par Value (20,000 underlying)
    20,000
  • Employee Stock Option

    Exercise: $6.46From: 2011-07-27Exp: 2020-07-27Common Stock, $.0001 Par Value (10,000 underlying)
    10,000
  • Employee Stock Option

    Exercise: $4.24From: 2012-03-01Exp: 2021-03-01Common Stock, $.0001 Par Value (20,000 underlying)
    20,000
  • Employee Stock Option

    Exercise: $4.42From: 2012-04-26Exp: 2021-04-26Common Stock, $.0001 Par Value (50,000 underlying)
    50,000
  • Employee Stock Option

    Exercise: $6.62From: 2013-03-08Exp: 2022-03-08Common Stock, $.0001 Par Value (100,000 underlying)
    100,000
Footnotes (3)
  • [F1]Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.51 to $7.59 inclusive. The reporting person undertakes to provide to BioScrip, Inc., any security holder of BioScrip, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges forth in this footnote.
  • [F3]Unvested

Issuer

BioScrip, Inc.

CIK 0001014739

Entity typeother

Related Parties

1
  • filerCIK 0001519545

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 2:59 PM ET
Size
20.3 KB